TABLE 1.
Patient characteristics
| Total N = 61 | N (%) |
|---|---|
| Diagnosis | |
| Leukemia, Lymphoma, MDS | 42 (68) |
| LCH/HLH | 4 (7) |
| Nonmalignant | 15 (25) |
| Preparative regimen | |
| TBI-based | 23 (38) |
| Busulfan-based | 28 (46) |
| RIC or Cy/ATG | 10 (16) |
| Disease status | |
| CRI/untreated | 23 (38) |
| CR2 | 11 (18) |
| CR3 or refractory | 10 (16) |
| Nonmalignant | 17 (28) |
| GVHD prophylaxis | |
| CNI plus MTX | 48 (79) |
| CNI plus CellCept | 9 (15) |
| CNI plus steroids | 4 (6) |
| HLA | |
| 10/10 related | 25 (41) |
| <10/10 related | 3 (5) |
| 10/10 unrelated | 21 (34) |
| <10/10 unrelated | 12 (20) |
| ABO mismatch | |
| No mismatch | 36 (59) |
| Major mismatch | 13 (21) |
| Minor mismatch | 10 (16) |
| Bidirectional mismatch | 2 (3) |
| Sex mismatch | |
| None | 32 (53) |
| Female donor, male recipient | 21 (34) |
| Male donor, female recipient | 8 (13) |
| CMV status | |
| Donor (−), recipient (−) | 10 (16) |
| Donor (−), recipient (+) | 24 (40) |
| Donor (+), recipient (−) | 5 (8) |
| Donor (+), recipient (+) | 22 (36) |
| GVHD | |
| Acute | 18 (30) |
| Chronic | 8 (13) |